Multidisciplinary supportive care in systemic light chain amyloidosis

The immunoglobulin light-chain amyloidosis is a multisystemic disease which manifests by damage to the vital organs by light chain-derived amyloid fibril. Traditionally, the treatment has been directed to the underlying plasma cell clone with or without high dose chemotherapy followed by autologous...

Descripción completa

Detalles Bibliográficos
Autores principales: Maroun, Bou Zerdan, Allam, Sabine, Chaulagain, Chakra P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242830/
https://www.ncbi.nlm.nih.gov/pubmed/35593003
http://dx.doi.org/10.5045/br.2022.2021227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242830/
https://www.ncbi.nlm.nih.gov/pubmed/35593003
http://dx.doi.org/10.5045/br.2022.2021227

Ejemplares similares